CVS Caremark has finalized a $20 million settlement with the Securities and Exchange Commission over accusations that the company misled investors and used improper accounting to boost its performance several years ago.
The drugstore chain and pharmacy benefits manager had announced the settlement last August, when it also said it neither admitted nor denied anything in reaching the agreement.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.